Helene G. Rubeiz

Helene Rubeiz practices at The University of Chicago Medical Center in Chicago, Illinois.

Helene Rubeiz's NPI, 1538210513, was assigned on January 16, 2007. Helene Rubeiz holds Illinois license 036082222.

Helene Rubeiz's primary practice is The University of Chicago Medical Center, at 5841 S Maryland Ave, Chicago, IL 60637 in Cook County. The practice phone is (773) 702-1530.

Helene Rubeiz's primary practice is The University of Chicago Medical Center in Chicago, Illinois. Helene Rubeiz is also affiliated with University of Chicago Medical Center. The medical group on file is UChicago Medicine Physicians. Dmand AI also links Helene Rubeiz to 1 more hospital and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Helene Rubeiz practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Helene Rubeiz's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Helene Rubeiz is licensed in Illinois.

CMS data shows 478 Medicare services from Helene Rubeiz across 10 procedure codes in 2024, for 322 Medicare patients. Medicare paid $31,311 for them.

CMS counts 322 Medicare patients who saw Helene Rubeiz in 2024. The largest group is 65 to 74, with 138 patients. 75% of them have high blood pressure, and 72% have high cholesterol. 38% are also on Medicaid. Their average risk score is 1.88, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Helene Rubeiz's median patient age at 62, with 64% women.

In 2024, Helene Rubeiz wrote 605 Medicare Part D claims for 98 patients. 82% of them were for generic drugs. CMS names the drug for 435 of them, across 18 drugs with 11 or more claims each, at $667,125 in total drug cost. In 2023, CMS named 353 claims across 16 drugs.

Helene Rubeiz accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Helene Rubeiz as offering telehealth.

Dmand AI links 3 papers to Helene Rubeiz, published from 2023 to 2024. Helene Rubeiz's most frequent co-authors are Betty C. Soliven, Mohammed Alhaidar, MBBS and Adil Javed.

CMS Open Payments shows 9 general payments to Helene Rubeiz from 8 drug and device companies from 2016 to 2022. Food and beverage make up the largest share, 100% of the total. Novartis Pharmaceuticals Corporation paid the most, $122.